Cardiovascular effects of GLP‐1 and GLP‐1‐based therapies: implications for the cardiovascular continuum in diabetes?

M Burgmaier, C Heinrich, N Marx - Diabetic medicine, 2013 - Wiley Online Library
Diabet. Med. 30, 289–299 (2013) Abstract Aims Glucagon‐like peptide‐1 receptor agonists
and inhibitors of dipeptidyl peptidase‐4 that increase glucagon‐like peptide‐1 plasma …
被引用次数：45 相关文章

Cardiovascular effects of GLP‐1 and GLP‐1‐based therapies: implications for the cardiovascular continuum in diabetes?

M Burgmaier, C Heinrich, N Marx - Diabetic Medicine, 2013 - infona.pl
Diabet. Med. 30, 289–299 (2013) Abstract Aims Glucagon‐like peptide‐1 receptor agonists
and inhibitors of dipeptidyl peptidase‐4 that increase glucagon‐like peptide‐1 plasma …

Cardiovascular effects of GLP-1 and GLP-1-based therapies: implications for the cardiovascular continuum in diabetes?

M Burgmaier, C Heinrich, N Marx - … Medicine: a Journal of the British …, 2013 - europepmc.org
Aims Glucagon-like peptide-1 receptor agonists and inhibitors of dipeptidyl peptidase-4 that
increase glucagon-like peptide-1 plasma concentrations are current treatment options for …

Cardiovascular effects of GLP-1 and GLP-1-based therapies: implications for the cardiovascular continuum in diabetes?

M Burgmaier, C Heinrich, N Marx - Diabetic Medicine, 2013 - search.ebscohost.com
Abstract Diabet. Med. 30, 289-299 (2013) Abstract Aims Glucagon-like peptide-1 receptor
agonists and inhibitors of dipeptidyl peptidase-4 that increase glucagon-like peptide-1 …

Cardiovascular effects of GLP-1 and GLP-1-based therapies: implications for the cardiovascular continuum in diabetes?

M Burgmaier, C Heinrich… - Diabetic medicine: a …, 2013 - pubmed.ncbi.nlm.nih.gov
Aims Glucagon-like peptide-1 receptor agonists and inhibitors of dipeptidyl peptidase-4 that
increase glucagon-like peptide-1 plasma concentrations are current treatment options for …

[引用][C] Cardiovascular effects of GLP-1 and GLP-1-based therapies: implications for the cardiovascular continuum in diabetes?

M BURGMAIER, C HEINRICH, N MARX - Diabetic medicine, 2013 - pascal-francis.inist.fr
Cardiovascular effects of GLP-1 and GLP-1-based therapies: implications for the
cardiovascular continuum in diabetes? CNRS Inist Pascal-Francis CNRS Pascal and …